-
Hims & Hers Health Posts Mixed Q1 Amid Weight-Loss Product 'Noise': Analysts
Tuesday, May 12, 2026 - 12:01pm | 573Read More...Shares of Hims & Hers Health Inc (NYSE:HIMS) tanked in early trading on Tuesday, after the company Monday reported disappointing first-quarter results. Here are the key analyst insights: JPMorgan analyst Cory Carpenter reiterated an Overweight rating, while cutting the price target from $35 to...
-
TeraWulf Posts Q1 Strength: Analysts Remain Bullish On HPC Strength
Monday, May 11, 2026 - 12:18pm | 533Read More...TeraWulf Inc (NASDAQ:WULF) shares rose in early trading on Monday, after the company reported upbeat first-quarter results on Friday. Here are the key analyst insights: Needham analyst John Todaro reaffirmed a Buy rating, while raising the price target from $22 to $28. Rosenblatt Securities...
-
Block Posts Blowout Q1 On Cash App Strength; Raised Outlook Reflects Improvement In 2026, Analysts Say
Friday, May 8, 2026 - 12:18pm | 440Read More...Shares of Block Inc (NYSE:XYZ) rose in early trading on Thursday, after the company Thursday reported upbeat first-quarter results. Here are the key analyst insights: Needham analyst Mayank Tandon reiterated a Buy rating, while raising the price target from $90 to $95. BTIG analyst Andrew Harte...
-
Datadog Rips Higher As AI Customers Fuel Revenue Acceleration
Friday, May 8, 2026 - 11:34am | 701Read More...Shares of Datadog Inc (NASDAQ:DDOG) rallied in early trading on Thursday after the company reported upbeat first-quarter results. Here are the key analyst insights: Guggenheim Securities analyst Howard Ma maintained a Buy rating, while raising the price target from $175 to $225. KeyBanc Capital...
-
Recursion Eyes Breakthrough With REC-4881 Drug For Rare Genetic Condition, But Shares Pull Back
Thursday, May 7, 2026 - 1:04pm | 396Read More...Earlier this year, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) initiated discussions with the FDA for the design of a registrational study for its experimental drug REC-4881 in familial adenomatous polyposis (FAP), which represents a new way of treating this rare genetic condition without immediate...
-
Uber Zooms Ahead On Platform Strength, Analysts Revise Estimates After Q1 Print
Thursday, May 7, 2026 - 11:32am | 558Read More...Shares of Uber Technologies Inc (NYSE:UBER) fell in early trading on Thursday despite an upbeat first-quarter (Q1) report. Here are the key analyst insights: Goldman Sachs analyst Eric Sheridan maintained a Buy rating, while cutting the price target from $125 to $115. JPMorgan analyst Doug Anmuth...
-
This Hut 8 Analyst Raises Price Target Despite Q1 Miss
Thursday, May 7, 2026 - 11:27am | 534Read More...Shares of Hut 8 Corp (NASDAQ:HUT) tanked in early trading on Thursday, after the company reported downbeat first-quarter (Q1) results. The company signed a 15-year, 352 MW (megawatt) lease at its Beacon Point campus. Needham expects it to contribute more heavily toward the back end as the lease...
-
Arista Networks Posts Strong Q1, Analysts Say Supply Shortages Dampen Outlook
Wednesday, May 6, 2026 - 12:08pm | 592Read More...Shares of Arista Networks Inc (NYSE:ANET) tanked in early trading on Wednesday despite an upbeat first-quarter (Q1) report. Key Analyst Insights Rosenblatt Securities analyst Mike Genovese maintained a Buy rating, while raising the price target from $180 to $210. JPMorgan analyst Samik Chatterjee...
-
Fabrinet Posts Record Q3, But Don't Thank Nvidia: Analyst
Tuesday, May 5, 2026 - 12:58pm | 451Read More...Shares of Fabrinet (NYSE:FN) tanked in early trading on Tuesday, even after the company reported upbeat fiscal third-quarter results. Here are the key analyst insights: Rosenblatt Securities analyst Mike Genovese maintained a Buy rating, while raising the price target from $715 to $750. Needham...
-
Duolingo Posts Q1 Beat; Faces Softness In Monthly Active User Growth
Tuesday, May 5, 2026 - 11:57am | 475Read More...Shares of Duolingo Inc (NASDAQ:DUOL) tanked in early trading on Tuesday, even after the company reported upbeat first-quarter results. Here are the key analyst insights: DA Davidson analyst Wyatt Swanson maintained a Neutral rating and raised the price target from $85 to $90. Needham analyst Ryan...
-
Streaming Strength, Stock Strain: Paramount Skydance's Hit Quarter Comes With A Plot Twist
Tuesday, May 5, 2026 - 11:50am | 559Read More...Shares of Paramount Skydance Corp (NASDAQ:PSKY) declined in early trading on Tuesday, even after yesterday, when the company reported upbeat first-quarter results. • Paramount Skydance stock is showing notable weakness. What’s weighing on PSKY shares? The highlights of the company...
-
Vertex Pharmaceuticals Posts Mixed Q1; Investors Focus On Non-CF Pipeline For Growth
Tuesday, May 5, 2026 - 11:44am | 446Read More...Shares of Vertex Pharmaceuticals Inc (NASDAQ:VRTX) declined in early trading on Tuesday after the company reported mixed first-quarter results. The company's CF franchise shows strength, but investor focus is on the non-CF pipeline for additional growth opportunities, according to Needham. The...
-
Etsy Rally Case Builds: Stock Has Room To Run, Needham Says
Friday, May 1, 2026 - 12:28pm | 590Read More...Needham turned more bullish on Etsy Inc. (NYSE:ETSY) after first-quarter earnings, saying the online marketplace may have reached a key growth inflection point. ETSY stock is moving. See the chart and price action here. The firm reiterated its Buy rating and raised its price target to $85...
-
Reddit Rallies As Ad Growth Drowns Out User Miss
Friday, May 1, 2026 - 11:29am | 516Read More...Shares of Reddit Inc (NYSE:RDDT) rallied in early trading on Friday, after the company Thursday reported upbeat first-quarter results. Here are the key analyst insights: JPMorgan analyst Doug Anmuth reiterated a Neutral rating and price target of $200. DA Davidson analyst Wyatt Swanson maintained...
-
Roku Rewinds Doubters With Ad-Fueled Earnings Beat
Friday, May 1, 2026 - 10:33am | 704Read More...Shares of Roku Inc (NASDAQ:ROKU) rallied in early trading on Friday, after the company reported upbeat first-quarter results. Here are the key analyst insights: KeyBanc Capital Markets analyst Justin Patterson maintained an Overweight rating, while raising the price target from $140 to $150....















